GENE ONLINE|News &
Opinion
Blog

2025-11-28|

Ultra-Thin Electrodes Developed to Improve Accuracy of Combined TMS-EEG Brain Studies

by GOAI
Share To

Researchers have developed ultra-thin electrodes that enhance the efficiency and reliability of combining transcranial magnetic stimulation (TMS) with electroencephalography (EEG), a technique used to study brain dynamics. This advancement, achieved through the collaborative efforts of scientists including Gruenwald, Schreiner, and Sieghartsleitner, aims to address challenges in integrating these two technologies. The innovation focuses on improving signal quality and reducing interference during simultaneous TMS-EEG procedures.

The new electrodes are designed to be thinner than conventional ones, which minimizes distortions caused by electromagnetic fields generated during TMS. This improvement allows for more accurate EEG recordings while maintaining comfort for participants. Researchers highlight that this development could provide a more reliable method for studying brain activity and understanding neural processes. The findings represent a significant step forward in neuroengineering and may open new possibilities for exploring complex brain functions using non-invasive techniques.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: November 28, 2025

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
LATEST
AI-Driven Healthcare Transformation at Healthcare Expo Taiwan 2025
2025-12-05
How AWS Cloud Is Transforming Global Smart Healthcare and Trusted Research Environments
2025-12-03
MedTex 2025: Taiwan as Gateway for AI-Driven Medical Innovation and Global Capital
2025-12-03
FDA CBER Director Vinay Prasad Issues November 2025 Memo Addressing Vaccine Development and Regulatory Challenges
2025-12-03
FDA to Review 16 Drug Applications Including 8 New Molecular Entities by Year-End
2025-12-03
Stephen Durso Named CEO of Altimmune Inc. as Vipin Garg Steps Down
2025-12-03
Janux Therapeutics Shares Halve Despite Positive Phase I Trial Results for Solid Tumor Therapy
2025-12-03
EVENT
2025-12-06
The 67th ASH Annual Meeting and Exposition
Orlando, Florida, USA
2025-12-04
2025 Healthcare+ Expo Taiwan
Taipei, Taiwan
Scroll to Top